Immunotherapy Advances in Colorectal Cancer Treatment
A landmark study demonstrates that pembrolizumab combined with standard chemotherapy significantly extends progression-free survival in patients with mismatch repair-deficient colorectal cancer.
Research Hub
Treatment
Curated cancer research categorised as Treatment. View all research →